UPDATE: Deutsche Bank Initiates Coverage On Ligand Pharmaceuticals On Growing Royalty Play On Biopharma

By: via Benzinga
In a report published Tuesday, Deutsche Bank analyst Gregg Gilbert initiated coverage on Ligand Pharmaceuticals Inc. (NASDAQ: LGND) with ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.